Clinically translatable mitochondrial gene therapy in muscle using tandem mtZFN architecture.

Abstract excerpt

Mutations in the mitochondrial genome (mtDNA) often lead to clinical pathologies. Mitochondrially-targeted zinc finger nucleases (mtZFNs) have been successful in reducing the levels of mutation-bearing mtDNA both in vivo and in vitro, resulting in a shift in the genetic makeup of affected mitochondria and subsequently to phenotypic rescue. Given the uneven distribution in the mtDNA mutation load across tissues in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Dependovirus
• Share to Disease Models, Animal